Editas Medicine, Inc. (LON: 0IFK)
London
· Delayed Price · Currency is GBP · Price in USD 1.320
+0.060 (4.76%)
Jan 23, 2025, 1:05 PM BST
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of 89.81 million as of January 23, 2025. Its market cap has decreased by -85.36% in one year.
Market Cap
89.81M
Enterprise Value
-94.17M
Revenue
46.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.32
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from 425.65M to 89.81M, a decrease of -78.90%. That is a compound annual growth rate of -15.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.43B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |